NCT01434693View on ClinicalTrials.gov

Safety and Tolerability of Single Doses Oral CNDO 201 Trichuris Suis Ova in Patients With Crohn's Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

April 30, 2012

Study Completion Date

September 30, 2012

Conditions
Crohn's Disease
Interventions
BIOLOGICAL

Trichuris suis ova

single dose

OTHER

Placebo

Trial Locations (7)

11021

Long Island Clinical Research Associates, LLP, Great Neck

32256

Borland-Groover Clinic, Jacksonville

32789

Shafran Gastroenterology Center, Winter Park

48047

Clinical Research Institute of Michigan, LLC, Chesterfield

64064

Midwest Center for Clinical Research, Lee's Summit

65265

Center for Digestive & Liver Diseases, Inc, Mexico

92801

Advanced Clinical Research Institute, Anaheim

Sponsors
All Listed Sponsors
lead

Coronado Biosciences, Inc.

INDUSTRY